ID   TKT_HUMAN               Reviewed;         623 AA.
AC   P29401; A8K089; B4DE31; E7EPA7; Q8TBA3; Q96HH3;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 3.
DT   12-APR-2017, entry version 184.
DE   RecName: Full=Transketolase;
DE            Short=TK;
DE            EC=2.2.1.1 {ECO:0000269|PubMed:27259054};
GN   Name=TKT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=8419340;
RA   McCool B.A., Plonk S.G., Martin P.R., Singleton C.K.;
RT   "Cloning of human transketolase cDNAs and comparison of the nucleotide
RT   sequence of the coding region in Wernicke-Korsakoff and non-Wernicke-
RT   Korsakoff individuals.";
RL   J. Biol. Chem. 268:1397-1404(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Jung E.-H., Sheu K.-F.R.E., Szabo P., Blass J.P.;
RT   "Molecular cloning, sequence and chromosome localization of human
RT   transketolase.";
RL   Submitted (SEP-1993) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9115179; DOI=10.1007/PL00006179;
RA   Schenk G., Layfield R., Candy J.M., Duggleby R.G., Nixon P.F.;
RT   "Molecular evolutionary analysis of the thiamine-diphosphate-dependent
RT   enzyme, transketolase.";
RL   J. Mol. Evol. 44:552-572(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Kidney, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-21.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 224-623 (ISOFORM 1), AND PARTIAL PROTEIN
RP   SEQUENCE.
RC   TISSUE=Brain;
RX   PubMed=1567394; DOI=10.1016/S0006-291X(05)80312-2;
RA   Abedinia M., Layfield R., Jones S.M., Nixon P.F., Mattick J.S.;
RT   "Nucleotide and predicted amino acid sequence of a cDNA clone encoding
RT   part of human transketolase.";
RL   Biochem. Biophys. Res. Commun. 183:1159-1166(1992).
RN   [10]
RP   COFACTOR.
RX   PubMed=3248678; DOI=10.1016/0020-711X(88)90228-5;
RA   Jung E.H., Takeuchi T., Nishino K., Itokawa Y.;
RT   "Studies on the nature of thiamine pyrophosphate binding and
RT   dependency on divalent cations of transketolase from human
RT   erythrocytes.";
RL   Int. J. Biochem. 20:1255-1259(1988).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-295, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-275 AND THR-287, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-11; LYS-144; LYS-204;
RP   LYS-241; LYS-260 AND LYS-603, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-275; THR-287 AND
RP   SER-295, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-104; THR-287 AND
RP   SER-295, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   INVOLVEMENT IN SDDHD, VARIANT SDDHD CYS-318, CHARACTERIZATION OF
RP   VARIANT SDDHD CYS-318, CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=27259054; DOI=10.1016/j.ajhg.2016.03.030;
RA   Boyle L., Wamelink M.M., Salomons G.S., Roos B., Pop A., Dauber A.,
RA   Hwa V., Andrew M., Douglas J., Feingold M., Kramer N., Saitta S.,
RA   Retterer K., Cho M.T., Begtrup A., Monaghan K.G., Wynn J., Chung W.K.;
RT   "Mutations in TKT are the cause of a syndrome including short stature,
RT   developmental delay, and congenital heart defects.";
RL   Am. J. Hum. Genet. 98:1235-1242(2016).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3-620 IN COMPLEXES WITH
RP   CALCIUM AND THIAMINE PYROPHOSPHATE.
RX   PubMed=20667822; DOI=10.1074/jbc.M110.149955;
RA   Mitschke L., Parthier C., Schroder-Tittmann K., Coy J., Ludtke S.,
RA   Tittmann K.;
RT   "The crystal structure of human transketolase and new insights into
RT   its mode of action.";
RL   J. Biol. Chem. 285:31559-31570(2010).
CC   -!- FUNCTION: Catalyzes the transfer of a two-carbon ketol group from
CC       a ketose donor to an aldose acceptor, via a covalent intermediate
CC       with the cofactor thiamine pyrophosphate.
CC       {ECO:0000269|PubMed:27259054}.
CC   -!- CATALYTIC ACTIVITY: Sedoheptulose 7-phosphate + D-glyceraldehyde
CC       3-phosphate = D-ribose 5-phosphate + D-xylulose 5-phosphate.
CC       {ECO:0000269|PubMed:27259054}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:3248678};
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:3248678};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:3248678};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:3248678};
CC       Note=Binds 1 Mg(2+) ion per subunit. Can also utilize other
CC       divalent metal cations, such as Ca(2+), Mn(2+) and Co(2+).
CC       {ECO:0000269|PubMed:3248678};
CC   -!- COFACTOR:
CC       Name=thiamine diphosphate; Xref=ChEBI:CHEBI:58937;
CC         Evidence={ECO:0000269|PubMed:3248678};
CC       Note=Binds 1 thiamine pyrophosphate per subunit.
CC       {ECO:0000269|PubMed:3248678};
CC   -!- SUBUNIT: Homodimer.
CC   -!- INTERACTION:
CC       P54274:TERF1; NbExp=2; IntAct=EBI-1050560, EBI-710997;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P29401-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P29401-2; Sequence=VSP_045566;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Short stature, developmental delay, and congenital heart
CC       defects (SDDHD) [MIM:617044]: An autosomal recessive syndrome
CC       characterized by short stature, developmental delay, intellectual
CC       disability and congenital heart defects including ventricular
CC       septal defect, atrial septal defect and patent foramen ovale.
CC       Cataract and uveitis are observed in some patients.
CC       {ECO:0000269|PubMed:27259054}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the transketolase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Transketolase entry;
CC       URL="https://en.wikipedia.org/wiki/Transketolase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X67688; CAA47919.1; -; mRNA.
DR   EMBL; L12711; AAA61222.1; -; mRNA.
DR   EMBL; U55017; AAA98961.1; -; mRNA.
DR   EMBL; AK289454; BAF82143.1; -; mRNA.
DR   EMBL; AK293438; BAG56942.1; -; mRNA.
DR   EMBL; AC097015; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW65281.1; -; Genomic_DNA.
DR   EMBL; BC008615; AAH08615.1; -; mRNA.
DR   EMBL; BC009970; AAH09970.1; -; mRNA.
DR   EMBL; BC024026; AAH24026.2; -; mRNA.
DR   CCDS; CCDS2871.1; -. [P29401-1]
DR   CCDS; CCDS58834.1; -. [P29401-2]
DR   PIR; A45050; A45050.
DR   RefSeq; NP_001055.1; NM_001064.3. [P29401-1]
DR   RefSeq; NP_001128527.1; NM_001135055.2. [P29401-1]
DR   RefSeq; NP_001244957.1; NM_001258028.1. [P29401-2]
DR   RefSeq; XP_011532356.1; XM_011534054.1. [P29401-2]
DR   UniGene; Hs.89643; -.
DR   PDB; 3MOS; X-ray; 1.75 A; A=3-618.
DR   PDB; 3OOY; X-ray; 2.05 A; A/B=10-620.
DR   PDB; 4KXU; X-ray; 0.98 A; A=1-623.
DR   PDB; 4KXV; X-ray; 0.97 A; A=1-623.
DR   PDB; 4KXW; X-ray; 0.97 A; A=1-623.
DR   PDB; 4KXX; X-ray; 1.03 A; A=1-623.
DR   PDB; 4KXY; X-ray; 1.26 A; A/B=1-623.
DR   PDBsum; 3MOS; -.
DR   PDBsum; 3OOY; -.
DR   PDBsum; 4KXU; -.
DR   PDBsum; 4KXV; -.
DR   PDBsum; 4KXW; -.
DR   PDBsum; 4KXX; -.
DR   PDBsum; 4KXY; -.
DR   ProteinModelPortal; P29401; -.
DR   SMR; P29401; -.
DR   BioGrid; 112941; 166.
DR   IntAct; P29401; 17.
DR   MINT; MINT-3011391; -.
DR   STRING; 9606.ENSP00000405455; -.
DR   BindingDB; P29401; -.
DR   ChEMBL; CHEMBL4983; -.
DR   iPTMnet; P29401; -.
DR   PhosphoSitePlus; P29401; -.
DR   SwissPalm; P29401; -.
DR   BioMuta; TKT; -.
DR   DMDM; 1729976; -.
DR   REPRODUCTION-2DPAGE; IPI00643920; -.
DR   EPD; P29401; -.
DR   PaxDb; P29401; -.
DR   PeptideAtlas; P29401; -.
DR   PRIDE; P29401; -.
DR   TopDownProteomics; P29401-1; -. [P29401-1]
DR   DNASU; 7086; -.
DR   Ensembl; ENST00000423516; ENSP00000391481; ENSG00000163931. [P29401-2]
DR   Ensembl; ENST00000423525; ENSP00000405455; ENSG00000163931. [P29401-1]
DR   Ensembl; ENST00000462138; ENSP00000417773; ENSG00000163931. [P29401-1]
DR   GeneID; 7086; -.
DR   KEGG; hsa:7086; -.
DR   UCSC; uc011beq.4; human. [P29401-1]
DR   CTD; 7086; -.
DR   DisGeNET; 7086; -.
DR   GeneCards; TKT; -.
DR   HGNC; HGNC:11834; TKT.
DR   HPA; HPA029480; -.
DR   HPA; HPA029481; -.
DR   MalaCards; TKT; -.
DR   MIM; 606781; gene.
DR   MIM; 617044; phenotype.
DR   neXtProt; NX_P29401; -.
DR   OpenTargets; ENSG00000163931; -.
DR   PharmGKB; PA36537; -.
DR   eggNOG; KOG0523; Eukaryota.
DR   eggNOG; COG0021; LUCA.
DR   GeneTree; ENSGT00390000005240; -.
DR   HOGENOM; HOG000243868; -.
DR   HOVERGEN; HBG004036; -.
DR   InParanoid; P29401; -.
DR   KO; K00615; -.
DR   OMA; KAFGQAR; -.
DR   OrthoDB; EOG091G03M5; -.
DR   PhylomeDB; P29401; -.
DR   TreeFam; TF313097; -.
DR   BRENDA; 2.2.1.1; 2681.
DR   Reactome; R-HSA-163754; Insulin effects increased synthesis of Xylulose-5-Phosphate.
DR   Reactome; R-HSA-71336; Pentose phosphate pathway (hexose monophosphate shunt).
DR   SABIO-RK; P29401; -.
DR   ChiTaRS; TKT; human.
DR   EvolutionaryTrace; P29401; -.
DR   GenomeRNAi; 7086; -.
DR   PRO; PR:P29401; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163931; -.
DR   CleanEx; HS_TKT; -.
DR   ExpressionAtlas; P29401; baseline and differential.
DR   Genevisible; P29401; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005777; C:peroxisome; ISS:UniProtKB.
DR   GO; GO:0031982; C:vesicle; IDA:UniProtKB.
DR   GO; GO:0048037; F:cofactor binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004802; F:transketolase activity; IDA:UniProtKB.
DR   GO; GO:0046166; P:glyceraldehyde-3-phosphate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006098; P:pentose-phosphate shunt; TAS:Reactome.
DR   GO; GO:0009052; P:pentose-phosphate shunt, non-oxidative branch; NAS:UniProtKB.
DR   GO; GO:0040008; P:regulation of growth; IEA:Ensembl.
DR   GO; GO:0005999; P:xylulose biosynthetic process; TAS:Reactome.
DR   Gene3D; 3.40.50.920; -; 1.
DR   InterPro; IPR029061; THDP-binding.
DR   InterPro; IPR009014; Transketo_C/PFOR_II.
DR   InterPro; IPR005475; Transketolase-like_Pyr-bd.
DR   InterPro; IPR020826; Transketolase_BS.
DR   InterPro; IPR033248; Transketolase_C.
DR   InterPro; IPR005474; Transketolase_N.
DR   Pfam; PF02779; Transket_pyr; 1.
DR   Pfam; PF02780; Transketolase_C; 1.
DR   Pfam; PF00456; Transketolase_N; 1.
DR   SMART; SM00861; Transket_pyr; 1.
DR   SUPFAM; SSF52518; SSF52518; 2.
DR   SUPFAM; SSF52922; SSF52922; 1.
DR   PROSITE; PS00801; TRANSKETOLASE_1; 1.
DR   PROSITE; PS00802; TRANSKETOLASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Calcium;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Dwarfism; Magnesium; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Thiamine pyrophosphate; Transferase.
FT   CHAIN         1    623       Transketolase.
FT                                /FTId=PRO_0000191894.
FT   NP_BIND     123    125       Thiamine pyrophosphate.
FT   ACT_SITE    366    366       Proton donor. {ECO:0000250}.
FT   METAL       155    155       Magnesium.
FT   METAL       185    185       Magnesium.
FT   METAL       187    187       Magnesium; via carbonyl oxygen.
FT   BINDING      37     37       Substrate. {ECO:0000250}.
FT   BINDING      40     40       Thiamine pyrophosphate.
FT   BINDING      77     77       Thiamine pyrophosphate.
FT   BINDING     156    156       Thiamine pyrophosphate; via amide
FT                                nitrogen.
FT   BINDING     185    185       Thiamine pyrophosphate.
FT   BINDING     244    244       Thiamine pyrophosphate.
FT   BINDING     258    258       Substrate. {ECO:0000250}.
FT   BINDING     258    258       Thiamine pyrophosphate.
FT   BINDING     318    318       Substrate. {ECO:0000250}.
FT   BINDING     345    345       Substrate. {ECO:0000250}.
FT   BINDING     392    392       Thiamine pyrophosphate.
FT   BINDING     416    416       Substrate. {ECO:0000250}.
FT   BINDING     424    424       Substrate. {ECO:0000250}.
FT   BINDING     428    428       Thiamine pyrophosphate.
FT   BINDING     474    474       Substrate. {ECO:0000250}.
FT   SITE         37     37       Important for catalytic activity.
FT                                {ECO:0000250}.
FT   SITE        258    258       Important for catalytic activity.
FT                                {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES       6      6       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      11     11       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     104    104       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     144    144       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     204    204       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     232    232       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P40142}.
FT   MOD_RES     241    241       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     260    260       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     275    275       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     287    287       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     295    295       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P50137}.
FT   MOD_RES     538    538       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P40142}.
FT   MOD_RES     603    603       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ     146    146       S -> SLPSSWDYS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045566.
FT   VARIANT     181    181       I -> V (in dbSNP:rs17052920).
FT                                /FTId=VAR_052634.
FT   VARIANT     318    318       R -> C (in SDDHD; decreased of
FT                                transketolase activity;
FT                                dbSNP:rs782092363).
FT                                {ECO:0000269|PubMed:27259054}.
FT                                /FTId=VAR_077030.
FT   CONFLICT     30     31       TT -> SS (in Ref. 1; CAA47919).
FT                                {ECO:0000305}.
FT   CONFLICT     46     46       E -> V (in Ref. 1; CAA47919).
FT                                {ECO:0000305}.
FT   CONFLICT    224    230       LCKAFGQ -> AVQGLCE (in Ref. 9; AA
FT                                sequence). {ECO:0000305}.
FT   CONFLICT    366    366       E -> G (in Ref. 4; BAG56942).
FT                                {ECO:0000305}.
FT   CONFLICT    426    426       P -> A (in Ref. 1; CAA47919).
FT                                {ECO:0000305}.
FT   CONFLICT    585    587       THL -> KTM (in Ref. 2; AAA61222).
FT                                {ECO:0000305}.
FT   CONFLICT    608    623       DRDAIAQAVRGLITKA -> TGMPLHKL (in Ref. 9;
FT                                AA sequence). {ECO:0000305}.
FT   HELIX         9     33       {ECO:0000244|PDB:4KXV}.
FT   HELIX        38     42       {ECO:0000244|PDB:4KXV}.
FT   HELIX        45     53       {ECO:0000244|PDB:4KXV}.
FT   STRAND       70     75       {ECO:0000244|PDB:4KXV}.
FT   HELIX        76     78       {ECO:0000244|PDB:4KXV}.
FT   HELIX        79     88       {ECO:0000244|PDB:4KXV}.
FT   HELIX        94     99       {ECO:0000244|PDB:4KXV}.
FT   HELIX       128    141       {ECO:0000244|PDB:4KXV}.
FT   STRAND      149    155       {ECO:0000244|PDB:4KXV}.
FT   HELIX       156    159       {ECO:0000244|PDB:4KXV}.
FT   HELIX       161    172       {ECO:0000244|PDB:4KXV}.
FT   STRAND      178    184       {ECO:0000244|PDB:4KXV}.
FT   STRAND      189    192       {ECO:0000244|PDB:4KXV}.
FT   TURN        194    197       {ECO:0000244|PDB:4KXV}.
FT   HELIX       199    208       {ECO:0000244|PDB:4KXV}.
FT   STRAND      212    217       {ECO:0000244|PDB:4KXV}.
FT   HELIX       221    229       {ECO:0000244|PDB:4KXV}.
FT   STRAND      236    241       {ECO:0000244|PDB:4KXV}.
FT   TURN        244    247       {ECO:0000244|PDB:4KXV}.
FT   TURN        249    253       {ECO:0000244|PDB:4KXV}.
FT   HELIX       264    275       {ECO:0000244|PDB:4KXV}.
FT   STRAND      314    316       {ECO:0000244|PDB:4KXV}.
FT   HELIX       317    331       {ECO:0000244|PDB:4KXV}.
FT   STRAND      335    341       {ECO:0000244|PDB:4KXV}.
FT   HELIX       343    346       {ECO:0000244|PDB:4KXV}.
FT   HELIX       349    354       {ECO:0000244|PDB:4KXV}.
FT   HELIX       356    358       {ECO:0000244|PDB:4KXV}.
FT   STRAND      359    361       {ECO:0000244|PDB:4KXV}.
FT   HELIX       366    377       {ECO:0000244|PDB:4KXV}.
FT   HELIX       378    380       {ECO:0000244|PDB:4KXV}.
FT   STRAND      383    389       {ECO:0000244|PDB:4KXV}.
FT   HELIX       390    396       {ECO:0000244|PDB:4KXV}.
FT   HELIX       397    405       {ECO:0000244|PDB:4KXV}.
FT   STRAND      410    418       {ECO:0000244|PDB:4KXV}.
FT   HELIX       419    421       {ECO:0000244|PDB:4KXV}.
FT   HELIX       426    428       {ECO:0000244|PDB:4KXV}.
FT   STRAND      430    432       {ECO:0000244|PDB:4KXV}.
FT   HELIX       433    438       {ECO:0000244|PDB:4KXV}.
FT   STRAND      443    446       {ECO:0000244|PDB:4KXV}.
FT   HELIX       451    462       {ECO:0000244|PDB:4KXV}.
FT   STRAND      466    471       {ECO:0000244|PDB:4KXV}.
FT   STRAND      474    478       {ECO:0000244|PDB:4KXV}.
FT   STRAND      493    496       {ECO:0000244|PDB:4KXV}.
FT   STRAND      501    506       {ECO:0000244|PDB:4KXV}.
FT   HELIX       510    523       {ECO:0000244|PDB:4KXV}.
FT   TURN        524    526       {ECO:0000244|PDB:4KXV}.
FT   STRAND      528    533       {ECO:0000244|PDB:4KXV}.
FT   STRAND      535    539       {ECO:0000244|PDB:4KXV}.
FT   HELIX       542    551       {ECO:0000244|PDB:4KXV}.
FT   TURN        552    554       {ECO:0000244|PDB:4KXV}.
FT   STRAND      555    564       {ECO:0000244|PDB:4KXV}.
FT   HELIX       568    576       {ECO:0000244|PDB:4KXV}.
FT   STRAND      583    589       {ECO:0000244|PDB:4KXV}.
FT   HELIX       598    604       {ECO:0000244|PDB:4KXV}.
FT   HELIX       609    620       {ECO:0000244|PDB:4KXV}.
SQ   SEQUENCE   623 AA;  67878 MW;  176C89C02FD2712B CRC64;
     MESYHKPDQQ KLQALKDTAN RLRISSIQAT TAAGSGHPTS CCSAAEIMAV LFFHTMRYKS
     QDPRNPHNDR FVLSKGHAAP ILYAVWAEAG FLAEAELLNL RKISSDLDGH PVPKQAFTDV
     ATGSLGQGLG AACGMAYTGK YFDKASYRVY CLLGDGELSE GSVWEAMAFA SIYKLDNLVA
     ILDINRLGQS DPAPLQHQMD IYQKRCEAFG WHAIIVDGHS VEELCKAFGQ AKHQPTAIIA
     KTFKGRGITG VEDKESWHGK PLPKNMAEQI IQEIYSQIQS KKKILATPPQ EDAPSVDIAN
     IRMPSLPSYK VGDKIATRKA YGQALAKLGH ASDRIIALDG DTKNSTFSEI FKKEHPDRFI
     ECYIAEQNMV SIAVGCATRN RTVPFCSTFA AFFTRAFDQI RMAAISESNI NLCGSHCGVS
     IGEDGPSQMA LEDLAMFRSV PTSTVFYPSD GVATEKAVEL AANTKGICFI RTSRPENAII
     YNNNEDFQVG QAKVVLKSKD DQVTVIGAGV TLHEALAAAE LLKKEKINIR VLDPFTIKPL
     DRKLILDSAR ATKGRILTVE DHYYEGGIGE AVSSAVVGEP GITVTHLAVN RVPRSGKPAE
     LLKMFGIDRD AIAQAVRGLI TKA
//
